Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...

The global drug trade exhibits striking regional differences, with varying drug preferences across different parts of the world. However, a common thread unites these regions: The pervasive rise ...

Eli Lilly LLY announced positive topline results from two phase III studies, QWINT-1 and QWINT-3, which evaluated efsitora alfa, its once-weekly administered investigational insulin, in adults ...

The Dean of the Faculty of Renewable Natural Resources, University of Ibadan, Professor Adejoke Akinyele, has called on the federal government to eliminate the activities of middlemen in the food ...

Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U ...

The trial results come less than two months after the U.S. Food and Drug Administration rejected Novo Nordisk's application for approval of a once-weekly basal insulin for diabetes patients.

the drug companies claim that they ultimately have to raise list prices in order to pay the middlemen.

The overall safety of insulin efsitora was similar to that of daily basal insulin therapies. Topline data were announced from 2 studies in the QWINT phase 3 clinical development program ...